These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11954631)

  • 1. Risk evaluation and informed consent for ovum donation: a clinical perspective.
    Mastroianni L
    Am J Bioeth; 2001; 1(4):28-9. PubMed ID: 11954631
    [No Abstract]   [Full Text] [Related]  

  • 2. No news here.
    White G
    Am J Bioeth; 2001; 1(4):29-30. PubMed ID: 11954632
    [No Abstract]   [Full Text] [Related]  

  • 3. Egg donor solicitation: problems exist, but do abuses?
    Sauer MV
    Am J Bioeth; 2001; 1(4):1-2. PubMed ID: 11954620
    [No Abstract]   [Full Text] [Related]  

  • 4. Donation, disclosure, and deception.
    Dresser R
    Am J Bioeth; 2001; 1(4):15-6. PubMed ID: 11954622
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician obligation in oocyte procurement.
    Nisker JA
    Am J Bioeth; 2001; 1(4):22-3. PubMed ID: 11954627
    [No Abstract]   [Full Text] [Related]  

  • 6. Eggs for sale: how much is too much?
    Stock G
    Am J Bioeth; 2001; 1(4):26-7. PubMed ID: 11954630
    [No Abstract]   [Full Text] [Related]  

  • 7. How should IVF programs handle initial disclosure of information to prospective ovum donors?
    Strong C
    Am J Bioeth; 2001; 1(4):23-5. PubMed ID: 11954628
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk information provided to prospective oocyte donors in a preliminary phone call.
    Gurmankin AD
    Am J Bioeth; 2001; 1(4):3-13. PubMed ID: 11954633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring ovum donors' motivations and needs.
    Braverman AM
    Am J Bioeth; 2001; 1(4):16-7. PubMed ID: 11954623
    [No Abstract]   [Full Text] [Related]  

  • 10. Risky business: evaluating oocyte donation.
    Berg JW
    Am J Bioeth; 2001; 1(4):18. PubMed ID: 11954624
    [No Abstract]   [Full Text] [Related]  

  • 11. Can we broker eggs without making omelets?
    Kahn J
    Am J Bioeth; 2001; 1(4):14. PubMed ID: 11954621
    [No Abstract]   [Full Text] [Related]  

  • 12. Not such large payments, after all.
    Wertz DC
    Am J Bioeth; 2001; 1(4):W19. PubMed ID: 12862015
    [No Abstract]   [Full Text] [Related]  

  • 13. Putting risk in perspective.
    Brzyski RG
    Am J Bioeth; 2001; 1(4):25-6. PubMed ID: 11954629
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulating the fiction of informed consent in ART medicine.
    Daar JF
    Am J Bioeth; 2001; 1(4):19-20. PubMed ID: 11954625
    [No Abstract]   [Full Text] [Related]  

  • 15. The interests of egg donors: who is deceiving whom?
    Cohen CB
    Am J Bioeth; 2001; 1(4):20-1. PubMed ID: 11954626
    [No Abstract]   [Full Text] [Related]  

  • 16. What oocyte donors aren't told?
    Mullen MA
    Am J Bioeth; 2001; 1(4):W3. PubMed ID: 12858872
    [No Abstract]   [Full Text] [Related]  

  • 17. Selling human egg donation.
    Thomasma DC
    Am J Bioeth; 2001; 1(4):W2. PubMed ID: 12858871
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracting eggs: a study of recruitment in oocyte donation.
    Gurmankin AD
    Am J Bioeth; 2001; 1(4):W21. PubMed ID: 12862018
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations on ethical issues in obstetrics and gynecology.
    International Federation of Gynecology and Obstetrics
    Bull Med Ethics; 1997 Nov; No. 133():8-9. PubMed ID: 11655253
    [No Abstract]   [Full Text] [Related]  

  • 20. Product egg: egg selling in an Austrian IVF clinic.
    Riegler J; Weikert A
    Reprod Genet Eng; 1988; 1(3):221-3. PubMed ID: 11650395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.